发明名称 |
IOTA-CARRAGENINA EM UMA QUANTIDADE ANTIVIRAL EFICAZ. |
摘要 |
<p>The present invention provides for the use of iota- and/or kappa-carrageenan for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus, paramyxovirus, adenovirus and coronavirus. The present invention further provides for the use of fucoidan, in particular of high molecular weight fucoidan, for the manufacture of an antiviral pharmaceutical composition for the prophylaxis or treatment of a pathological condition or disease caused by or associated with an infection by a respiratory virus selected from the group consisting of orthomyxovirus and paramyxovirus.</p> |
申请公布号 |
BRPI0815748(A2) |
申请公布日期 |
2015.02.18 |
申请号 |
BR2008PI15748 |
申请日期 |
2008.08.22 |
申请人 |
MARINOMED BIOTECHNOLOGIE GMBH |
发明人 |
ANDREAS GRASSAUER;EVA PRIESCHL-GRASSAUER |
分类号 |
A61K31/431;A61K31/737;A61P31/14;A61P31/16;A61P31/20 |
主分类号 |
A61K31/431 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|